The increasing volume and complexity of product-related cases, ranging from customer complaints to adverse event reports, have placed significant operational and compliance burdens on organisations. Traditional manual triage processes are often slow, inconsistent, and difficult to audit. This white paper introduces CollabTriage Drugs, an AI-based case triage system designed to automate the classification, seriousness assessment, and regulatory routing of product-related cases. By combining artificial intelligence, rule-based validation, and human oversight, CollabTriage Drugs delivers a scalable, consistent, and auditable solution aligned with global and regional regulatory requirements.
Organizations operating in regulated environments must process large volumes of product-related cases originating from diverse sources such as customer feedback, complaints, and adverse event reports. These cases frequently contain multiple issues, each of which may require independent evaluation and regulatory consideration.
Historically, initial case triage has relied heavily on manual review, resulting in extended processing timelines, subjective decision-making, and inconsistent outcomes. As regulatory expectations continue to rise, there is a growing need for automation that preserves compliance, transparency, and human accountability.
CollabTriage Drugs addresses this need by introducing an AI-enabled, rule-driven framework for standardized case triage and regulatory assessment.
CollabTriage Drugs is an AI-based case triage system that automates the initial assessment of product-related cases received from the market. The system validates incoming data, classifies issues by seriousness, and routes cases to the appropriate regulatory workflows.
A key foundation of the solution is the enforcement of PREP validation — Patient, Reporter, Event, and Product, as a mandatory gating mechanism. Only cases meeting PREP requirements are eligible for automated regulatory assessment. Cases are categorised into Serious, Non-Serious and these categories are customizable.
The adoption of CollabTriage Drugs delivers measurable operational and compliance benefits:
By standardizing decision logic and embedding compliance checks early in the process, the system strengthens the organization's regulatory posture while improving efficiency.
The primary objective of CollabTriage Drugs is to standardize and automate the initial triage of product-related cases while ensuring full regulatory compliance.
Key Objectives:
Cases are ingested in a structured data format, with each case potentially containing multiple issues requiring independent evaluation.
Each case must include the following mandatory elements:
Cases missing any PREP component are marked as invalid or routed for manual review, ensuring data integrity prior to regulatory processing.
Each issue within a case is classified independently as:
If at least one issue is identified as serious, the entire case is classified as serious, ensuring conservative and compliant escalation.
Based on product type and geographic region, additional regulatory logic is applied.
CollabTriage Drugs is built on a secure and scalable technology foundation:
The system implements clearly defined and auditable logic:
Discover how CollabTriage Drugs can streamline your medical device operations, reduce compliance risk, and accelerate time-to-market. Schedule a personalized demo with our experts today.
